補完代替医療の世界市場:インターベンション別(磁気、エネルギーヒーリング)、流通経路別(Eセールス、直接販売)、地域別

◆英語タイトル:Complementary And Alternative Medicine Market Size, Share & Trends Analysis Report By Intervention (Magnetic Intervention, Energy Healing), By Distribution Method (E-Sales, Direct Sales), By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY040
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年2月19日
◆ページ数:190
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、補完代替医療の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、インターベンション別(磁気、エネルギーヒーリング)分析、流通経路別(Eセールス、直接販売)分析、地域別分析、競争状況などの構成でお届けいたします。
・調査手法
・エグゼクティブサマリー
・市場要因・動向・範囲
・競争分析
・補完代替医療の世界市場:インターベンション別(磁気、エネルギーヒーリング)
・補完代替医療の世界市場:流通経路別(Eセールス、直接販売)
・補完代替医療の世界市場:地域別
・競争状況
【レポートの概要】

The global complementary and alternative medicine market size is projected to reach USD 296.3 billion by 2027, exhibiting a CAGR of 19.9%, according to a new report by Grand View Research, Inc. A comparatively high demand for alternative medicine across developing countries and expanding applications of traditional medicine practiced in Asia are two key driving factors of the market. China and India are the key contributors to the Asia Pacific region and thus are offering significant momentum to the revenue generation by complementary and alternative treatment through the study period.

In addition, increase in the number of licensed and trained physicians who can offer state-of-the-art complementary therapies is set to boost patient preference toward traditional medicine. It is becoming integral in the healthcare system in Asia, especially in China wherein most of the hospitals in the country have distinct departments and wards that are dedicated to traditional therapeutic approaches.

Moreover, in terms of research, CAM has reached a remunerative stage. This can be attributed to the rising pool of scientists working at established universities across U.S., Europe, and Asia Pacific who are focusing on building a robust foundation for the alternative treatment targeted toward Parkinson’s disease, cancer, and diabetes.

Further key findings from the report suggest:

• Botanicals are the most ancient form of alternative treatment practices, which include herbal and natural treatment supplements along with another natural form of treatments incorporating oils, herbs, and other curative supplements

• The botanicals intervention segment dominated the global market throughout the study period, whereas magnetic intervention is expected to grow at the fastest rate from 2020 to 2027

• Mind and body healing oriented traditional medicines are some of the most frequently adopted forms of alternate therapies worldwide. Mind and body intervention incorporates various forms of energy and mind exercises to heal ailments

• Yoga has dominated the global complementary and alternative medicine market throughout the study period, whereas hypnotherapy is projected to witness the highest growth rate over the forecast period

• Europe is anticipated to witness highest market share over the forecast period. Rising preference for alternative treatment approaches among patients will drive the regional market for complementary and alternative medicine.

• Key industry participants include Nordic Nutraceuticals, Pure encapsulations, LLC, AYUSH Ayurvedic Pte Ltd, and Sheng Chang Pharmaceutical Company

• Companies are inclined toward strategic partnerships to establish their presence in the market; for instance, in June 2019, AstraZeneca partnered with Luye Pharma Group to market a herbal therapy

• The herbal medicine product is developed from red yeast rice and is formulated to assist patients suffering from cholesterol. With this partnership, AstraZeneca is set to expand its business across China.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Primary Research: Questionnaire
1.1.1.1 Key market participants/ in-house industry experts
1.1.1.2 Key end-users
1.2 Information or Data Analysis
1.3 Market Scope & Segment Definition
1.3.1 By intervention
1.3.1.1 Botanicals
1.3.1.2 Mind/body healing
1.3.1.3 Acupuncture
1.3.1.4 Magnetic interventions
1.3.2 By distribution method
1.3.2.1 Direct
1.3.2.2 E-sales
1.3.2.3 Distance correspondance
1.4 Market Analysis
1.4.1 Service landscape
1.4.1.1 Types of service providers
1.4.1.1.1 Key facts about chiropractors & other CAM providers in the U.S.
1.4.1.2 Number of registered practitioners
1.4.1.3 Regulatory framework study
1.4.1.4 Service mapping, by region
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Complementary and Alternative Medicine Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.2 Penetration & Growth Prospect Mapping, By Intervention, 2019
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Market influencer analysis
3.4 Regulatory Framework
3.4.1 Reimbursement framework
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Growing awareness of wellness medicine
3.5.1.2 Growing recognition and coverage
3.5.1.3 Government initiatives and changing regulatory status
3.5.1.4 Demographic changes drive demand
3.5.2 Market restraint analysis
3.5.2.1 Lack of scientific results
3.5.2.2 Challenges associated with integration
3.5.3 Market opportunity analysis
3.5.3.1 Opioid addiction crisis drives demand for alternative therapies
3.5.3.2 New research studies supporting use of CAM care in back treatment
3.5.3.3 Growing use of internet & social media platforms
3.5.3.4 Transition in physician’s attitude
3.5.3.5 Incorporation of CAM in the healthcare system of developing economies
3.5.4 Industry challenges analysis
3.5.4.1 Presence of established conventional treatment options
3.5.4.2 Less number of training programs in developing regions Less number of training programs in developing regions
3.6 Complementary and Alternative Medicine: Market Analysis Tools
3.6.1 Industry analysis – Porter’s
3.6.1.1 Supplier powers
3.6.1.2 Buyer powers
3.6.1.3 Threat of subsitution
3.6.1.4 Threat of new entrants
3.6.1.5 Competive rivalry
3.6.2 PESTEL analysis
3.6.2.1 Political landscape
3.6.2.2 Economic landscape
3.6.2.3 Social landscape
3.6.2.4 Technology landscape
3.6.2.5 Environmental landscape
3.6.2.6 Legal landscape
3.6.3 Major deals & strategic alliances analysis
3.6.3.1 Joint ventures
3.6.3.2 Mergers & acquisitions
3.6.3.3 Collaborations & partnership
3.6.4 Market entry strategies
Chapter 4 Complementary and Alternative Medicine Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Competition Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.4 Private Companies
4.4.1 List of key emerging companies/innovators
4.4.2 Funding outlook
4.4.3 Company market position analysis
Chapter 5 Complementary and Alternative Medicine Market: Intervention Estimates & Trend Analysis
5.1 Complementary and Alternative Medicine Market: Intervention Movement Analysis
5.2 Botanicals
5.2.1 Botanicals complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.2.2 Ayurveda
5.2.2.1 Ayurveda complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.2.3 Naturopathy
5.2.3.1 Naturopathy complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.2.4 Homeopathy
5.2.4.1 Homeopathy complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.3 Mind & Body Healing
5.3.1 Mind & body healing complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.3.2 Yoga
5.3.2.1 Yoga complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.3.3 Meditation
5.3.3.1 Meditation complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.3.4 Energy healing
5.3.4.1 Energy healing complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.3.4.2 Eden energy medicine
5.3.4.2.1 Eden energy complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.3.4.3 Other energy healing medicine
5.3.4.3.1 Other energy healing complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.3.5 Chakra healing
5.3.5.1 Chakra healing complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.3.6 Hypnotherapy
5.3.6.1 Hypnotherapy complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.3.7 Kinesiology
5.3.7.1 Kinesiology complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.4 Magnetic Intervention
5.4.1 Magnetic intervention complementary and alternative medicine, 2016 – 2027 (USD Billion)
5.4.2 Magnetic resonance therapy
5.4.2.1 Magnetic resonance therapy complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.4.3 Bio-magnetic therapy
5.4.3.1 Bio-magnetic therapy complementary and alternative medicine market, 2016 – 2027 (USD Billion)
5.5 Accupunture
5.5.1 Acupuncture complementary and alternative medicine, 2016 – 2027 (USD Billion)
Chapter 6 Complementary and Alternative Medicine Market: Distribution Method Estimates & Trend Analysis
6.1 Complementary and Alternative Medicine Market: Distribution Method Movement Analysis
6.2 Direct Sales
6.2.1 Direct sales-based complementary and alternative medicine market, 2016 – 2027 (USD Billion)
6.3 E-sales
6.3.1 E-sales-based complementary and alternative medicine market, 2016 – 2027 (USD Billion)
6.4 Distance Correspondence
6.4.1 Distance correspondence-based complementary and alternative medicine market, 2016 – 2027 (USD Billion)
Chapter 7 Complementary and Alternative Medicine: Regional Estimates & Trend Analysis, by Intervention and Distribution Method
7.1 Alternative Medicine Market Share By Region, 2019 & 2027
7.2 North America
7.2.1 Complementary and alternative medicine market, 2016 – 2027 (USD Billion)
7.2.2 U.S.
7.2.2.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.2.2.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.2.3 Canada
7.2.3.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.2.3.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3 Europe
7.3.1 Complementary and alternative medicine market, 2016 – 2027 (USD Billion)
7.3.2 Germany
7.3.2.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.2.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.3 France
7.3.3.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.3.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.4 U.K.
7.3.4.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.4.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.5 Switzerland
7.3.5.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.5.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.6 Austria
7.3.6.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.6.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.7 Spain
7.3.7.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.7.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.8 Norway
7.3.8.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.8.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.9 Denmark
7.3.9.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.9.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.10 Sweden
7.3.10.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.10.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.11 Belgium
7.3.11.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.11.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.12 Netherlands
7.3.12.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.12.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.3.13 Ireland
7.3.13.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.3.13.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.4 Asia Pacific
7.4.1 Complementary and alternative medicine market, 2016 – 2027 (USD Billion)
7.4.2 China
7.4.2.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.4.2.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.4.3 India
7.4.3.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.4.3.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.4.4 Japan
7.4.4.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.4.4.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.4.5 Australia
7.4.5.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.4.5.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.4.6 New Zealand
7.4.6.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.4.6.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.4.7 Singapore
7.4.7.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.4.7.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.4.8 Hong Kong
7.4.8.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.4.8.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.5 Latin America
7.5.1 Complementary and alternative medicine market, 2016 – 2027 (USD Billion)
7.5.2 Brazil
7.5.2.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.5.2.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.5.3 Mexico
7.5.3.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.5.3.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.5.4 Argentina
7.5.4.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.5.4.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.6 Middle East and Africa
7.6.1 Complementary and alternative medicine market, 2016 – 2027 (USD Billion)
7.6.2 UAE
7.6.2.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.6.2.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.6.3 South Africa
7.6.3.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.6.3.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
7.6.4 Israel
7.6.4.1 Complementary and alternative medicine market, by intervention, 2016 – 2027 (USD Billion)
7.6.4.2 Complementary and alternative medicine market, by distribution method, 2016 – 2027 (USD Billion)
Chapter 8 Competitive Landscape
8.1 Columbia Nutritional
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product/service benchmarking
8.1.4 Strategic initiatives
8.2 Herb Pharm
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product/service benchmarking
8.2.4 Strategic initiatives
8.3 Herbal Hills
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product/service benchmarking
8.3.4 Strategic initiatives
8.4 Ramamani Iyengar Memorial Yoga Institute
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product/service benchmarking
8.4.4 Strategic initiatives
8.5 triyoga
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product/service benchmarking
8.5.4 Strategic initiatives
8.6 Yoga Tree Studios, Inc.
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product/service benchmarking
8.6.4 Strategic initiatives
8.7 Helio USA Inc.
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product/service benchmarking
8.7.4 Strategic initiatives
8.8 NatureKue, Inc.
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product/service benchmarking
8.8.4 Strategic initiatives
8.9 Nordic Nutraceuticals
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product/service benchmarking
8.9.4 Strategic initiatives
8.10 Pure Encapsulations, LLC.
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product/service benchmarking
8.10.4 Strategic initiatives
8.11 The Healing Company Ltd.
8.11.1 Company overview
8.11.2 Financial performance
8.11.3 Product/service benchmarking
8.11.4 Strategic initiatives
8.12 Quantum-Touch
8.12.1 Company overview
8.12.2 Financial performance
8.12.3 Product/service benchmarking
8.12.4 Strategic initiatives
8.13 BIOTAILOR
8.13.1 Company overview
8.13.2 Financial performance
8.13.3 Product/service benchmarking
8.13.4 Strategic initiatives
8.14 Vitalia Health
8.14.1 Company overview
8.14.2 Financial performance
8.14.3 Product/service benchmarking
8.14.4 Strategic initiatives
8.15 Biomag Medical s.r.o.
8.15.1 Company overview
8.15.2 Financial performance
8.15.3 Product/service benchmarking
8.15.4 Strategic initiatives
8.16 The Ashdown Clinic Limited
8.16.1 Company overview
8.16.2 Financial performance
8.16.3 Product/service benchmarking
8.16.4 Strategic initiatives
8.17 BiomagScience
8.17.1 Company overview
8.17.2 Financial performance
8.17.3 Product/service benchmarking
8.17.4 Strategic initiatives
8.18 Atkins Health Center
8.18.1 Company overview
8.18.2 Financial performance
8.18.3 Product/service benchmarking
8.18.4 Strategic initiatives
8.19 LKK Health Products Group Limited.
8.19.1 Company overview
8.19.2 Financial performance
8.19.3 Product/service benchmarking
8.19.4 Strategic initiatives
8.20 Body & Soul Yoga Club
8.20.1 Company overview
8.20.2 Financial performance
8.20.3 Product/service benchmarking
8.20.4 Strategic initiatives
8.21 lifemark.ca
8.21.1 Company overview
8.21.2 Financial performance
8.21.3 Product/service benchmarking
8.21.4 Strategic initiatives
8.22 Fit to Function Kinesiology
8.22.1 Company overview
8.22.2 Financial performance
8.22.3 Product/service benchmarking
8.22.4 Strategic initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 Chances of heart diseases associated with CRP levels in blood
TABLE 3 Estimated new female cases of breast cancer & deaths in the U.S., 2017
TABLE 4 North America C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 5 North America C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 6 North America C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 7 North America C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 8 North America C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 9 North America C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 10 North America C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 11 North America C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 12 North America C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 13 North America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 14 U.S. C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 15 U.S. C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 16 U.S. C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 17 U.S. C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 18 U.S. C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 19 U.S. C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 20 U.S. C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 21 U.S. C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 22 U.S. C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 23 U.S. C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 24 Canada C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 25 Canada C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 26 Canada C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 27 Canada C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 28 Canada C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 29 Canada C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 30 Canada C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 31 Canada C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 32 Canada C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 33 Canada C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 34 Europe C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 35 Europe C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 36 Europe C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 37 Europe C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 38 Europe C-reactive protein testing market, by end-use, 2016 - 2027 (USD Million)
TABLE 39 Europe C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 40 Europe C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 41 Europe C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 42 Europe C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 43 Europe C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 44 Germany C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 45 Germany C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 46 Germany C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 47 Germany C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 48 Germany C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 49 Germany C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 50 Germany C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 51 Germany C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 52 Germany C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 53 Germany C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 54 U.K. C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 55 U.K. C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 56 U.K. C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 57 U.K. C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 58 U.K. C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 59 U.K. C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 60 U.K. C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 61 U.K. C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 62 U.K. C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 63 U.K. C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 64 Asia Pacific C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 65 Asia Pacific C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 66 Asia Pacific C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 67 Asia Pacific C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 68 Asia Pacific C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 69 Asia Pacific C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 70 Asia Pacific C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 71 Asia Pacific C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 72 Asia Pacific C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 73 Asia Pacific C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 74 Japan C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 75 Japan C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 76 Japan C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 77 Japan C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 78 Japan C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 79 Japan C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 80 Japan C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 81 Japan C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 82 Japan C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 83 Japan C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 84 China C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 85 China C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 86 China C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 87 China C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 88 China C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 89 China C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 90 China C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 91 China C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 92 China C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 93 China C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 94 Latin America C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 95 Latin America C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 96 Latin America C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 97 Latin America C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 98 Latin America C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 99 Latin America C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 100 Latin America C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 101 Latin America C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 102 Latin America C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 103 Latin America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 104 Brazil C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 105 Brazil C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 106 Brazil C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 107 Brazil C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 108 Brazil C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 109 Brazil C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 110 Brazil C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 111 Brazil C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 112 Brazil C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 113 Brazil C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 114 MEA C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 115 MEA C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 116 MEA C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 117 MEA C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 118 MEA C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 119 MEA C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 120 MEA C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 121 MEA C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 122 MEA C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 123 MEA C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 124 South Africa C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
TABLE 125 South Africa C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
TABLE 126 South Africa C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
TABLE 127 South Africa C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
TABLE 128 South Africa C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
TABLE 129 South Africa C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
TABLE 130 South Africa C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
TABLE 131 South Africa C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
TABLE 132 South Africa C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
TABLE 133 South Africa C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
TABLE 134 List of key emerging companies


List of Figures

FIG. 1 Market research process
FIG. 2 Data triangulation techniques
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Market summary
FIG. 9 Market trends & outlook
FIG. 10 Market segmentation & scope
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Technology timeline: CRP detection
FIG. 14 Antibiotic prescribing decisions pre- and post-CRP tests in UCC study
FIG. 15 Penetration & growth prospect mapping for assay type, 2019
FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 17 Porter’s Five Forces Analysis
FIG. 18 Global C-reactive protein testing market: Assay type outlook key takeaways
FIG. 19 Global C-reactive protein testing market: Assay type movement analysis
FIG. 20 Global immunoturbidimetric assay market, 2016 - 2027 (USD Million)
FIG. 21 Global ELISA market, 2016 - 2027 (USD Million)
FIG. 22 Global clinical ELISA market, 2016 - 2027 (USD Million)
FIG. 23 Global nonclinical ELISA market, 2016 - 2027 (USD Million)
FIG. 24 Global chemiluminescence immunoassay market, 2016 - 2027 (USD Million)
FIG. 25 Global others market, 2016 - 2027 (USD Million)
FIG. 26 Global C-reactive protein testing market: Detection range estimates outlook key takeaways
FIG. 27 Global C-reactive protein testing market: Detection range movement analysis
FIG. 28 Global hsCRP market, 2016 - 2027 (USD Million)
FIG. 29 Global conventional CRP market, 2016 - 2027 (USD Million)
FIG. 30 Global cardiac CRP market, 2016 - 2027 (USD Million)
FIG. 31 Global C-reactive protein testing market: Disease area estimates outlook key takeaways
FIG. 32 Global C-reactive protein testing market: Disease Area movement analysis
FIG. 33 Global cardiovascular diseases CRP testing market, 2016 - 2027 (USD Million)
FIG. 34 Global cancer CRP testing market, 2016 - 2027 (USD Million)
FIG. 35 Global rheumatoid arthritis CRP testing market, 2016 - 2027 (USD Million)
FIG. 36 Global inflammatory bowel disease CRP testing market, 2016 - 2027 (USD Million)
FIG. 37 Global endometriosis CRP testing market, 2016 - 2027 (USD Million)
FIG. 38 Global lupus CRP testing market, 2016 - 2027 (USD Million)
FIG. 39 Global others market, 2016 - 2027 (USD Million)
FIG. 40 Global C-reactive protein testing market: End-use estimates outlook key takeaways
FIG. 41 Global C-reactive protein testing market: End-use movement analysis
FIG. 42 Global clinics market, 2016 - 2027 (USD Million)
FIG. 43 Physician office visits in the U.S., by age (Thousands)
FIG. 44 Global physician office market, 2016 - 2027 (USD Million)
FIG. 45 Global small clinic market, 2016 - 2027 (USD Million)
FIG. 46 Global other clinics market, 2016 - 2027 (USD Million)
FIG. 47 Global urban setting clinics market, 2016 - 2027 (USD Million)
FIG. 48 Global rural settings clinic market, 2016 - 2027 (USD Million)
FIG. 49 Global hospitals market, 2016 - 2027 (USD Million)
FIG. 50 Global urban setting hospitals market, 2016 - 2027 (USD Million)
FIG. 51 Global rural setting hospitals market, 2016 - 2027 (USD Million)
FIG. 52 Global laboratories market, 2016 - 2027 (USD Million)
FIG. 53 Global urban setting laboratories market, 2016 - 2027 (USD Million)
FIG. 54 Global rural setting laboratories market, 2016 - 2027 (USD Million)
FIG. 55 Global assisted living healthcare facilities market, 2016 - 2027 (USD Million)
FIG. 56 Global urban setting assisted living healthcare facilities market, 2016 - 2027 (USD Million)
FIG. 57 Global rural setting assisted living healthcare facilities market, 2016 - 2027 (USD Million)
FIG. 58 Global home market, 2016 - 2027 (USD Million)
FIG. 59 Global others market, 2016 - 2027 (USD Million)
FIG. 60 Regional marketplace: Key takeaway
FIG. 61 Global C-reactive protein testing market regional outlook, 2019 & 2027
FIG. 62 North America C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 63 U.S. C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 64 Canada C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 65 Europe C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 66 Germany C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 67 U.K. C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 68 Asia Pacific C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 69 Japan C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 70 China C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 71 Latin America C-reactive protein testing market, 2016-2027 (USD Million)
FIG. 72 Brazil C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 73 Middle East & Africa C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 74 South Africa C-reactive protein testing market, 2016 - 2027 (USD Million)
FIG. 75 Participant categorization
FIG. 76 Impact analysis by key companies
FIG. 77 Market position analysis for public companies
FIG. 78 Strategy framework

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[補完代替医療の世界市場:インターベンション別(磁気、エネルギーヒーリング)、流通経路別(Eセールス、直接販売)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆